Left Ventricular Global Longitudinal Systolic Strain Predicts Adverse Remodeling and Subsequent Cardiac Events in Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
Overview
Authors
Affiliations
To determine whether left ventricular (LV) global longitudinal strain (GLS) predicts adverse LV remodeling and cardiac events. In a prospective cohort study of patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI), we recorded clinical data and GLS, global circumferential strain and radial strain using two-dimensional speckle-tracking echocardiography of the left ventricle. At 6-month and 3-year follow-ups, patients were grouped by presence or absence of adverse LV remodeling. We used logistic regression to identify factors associated with adverse LV remodeling and a Cox model to determine the relationships between these factors and cardiac events. Of 97 patients (mean age 56 ± 12 years; 76 men), 38 showed LV remodeling. Diabetes mellitus [odds ratio (OR) 1.95% confidence interval (CI) 1.2-4.8, p = 0.05], peak troponin I (OR 1.2, 95% CI 1.1-1.3, p = 0.004), and GLS (OR 1.6, 95% CI 1.3-2.3, p = 0.009) independently predicted LV remodeling. During follow-up (22.8 ± 12.3 months), 20 patients suffered adverse events, which were independently predicted by GLS alone (OR 4.9, 95% CI 1.7-13.9, p = 0.002). Optimal GLS cutoffs for predicting adverse LV remodeling and cardiac events were >-12.46% [area under receiver operating-characteristic curve (AUC) 0.88, 95% CI 0.79-0.96, p < 0.001] and >-9.27% (AUC 0.86, 95% CI 0.64-0.98, p < 0.001), respectively. GLS measured immediately after primary PCI is an excellent predictor of adverse LV remodeling and cardiac events in patients with AMI.
Identification of Pre-Heart Failure in Early Stages: The Role of Six Stages of Heart Failure.
Jankajova M, Singh R, Hristova K, Elkilany G, Fatima G, Singh J Diagnostics (Basel). 2024; 14(23).
PMID: 39682527 PMC: 11640183. DOI: 10.3390/diagnostics14232618.
Zia-Ul-Sabah , Alqahtani S, Alghamdi B, Wani J, Aziz S, Durrani H BMC Cardiovasc Disord. 2024; 24(1):600.
PMID: 39468433 PMC: 11520066. DOI: 10.1186/s12872-024-04254-7.
Bosa Ojeda F, Mendez Vargas C, Lacalzada Almeida J, Izquierdo Gomez M, Jimenez Sosa A, Rodriguez Jimenez C Catheter Cardiovasc Interv. 2024; 104(7):1414-1422.
PMID: 39425551 PMC: 11667407. DOI: 10.1002/ccd.31267.
Chaichuum S, Tseng C, Chang S, Chan C, Hsu C, Chiang E Sci Rep. 2024; 14(1):10849.
PMID: 38740940 PMC: 11091216. DOI: 10.1038/s41598-024-61641-y.
Singh R, Fedacko J, Pella D, Fatima G, Elkilany G, Moshiri M Antioxidants (Basel). 2022; 11(8).
PMID: 36009183 PMC: 9404840. DOI: 10.3390/antiox11081464.